case_images: PMC4886031_01
case_images: Acute pulmonary oedema following rituximab treatment.
case_images: cnd-0006-0032-g01.jpg
case_images: PMC4886031_01_cnd-0006-0032-g01.jpg
case_images: F1
case_images: Two days after the initial dose of rituximab, she developed acute respiratory distress and was found to be in florid pulmonary oedema (fig. 1).
case_images: MRI of the brain showing high T2 and FLAIR signal in the occipital and posterior parietal subcortical white matter consistent with PRES following treatment with rituximab.
case_images: cnd-0006-0032-g02.jpg
case_images: PMC4886031_01_cnd-0006-0032-g02.jpg
case_images: F2
case_images: MRI of the head revealed subcortical white matter high T2 and FLAIR signal in the occipital and posterior parietal lobes consistent with PRES (fig. 2).